Top Stories
-
Source:
Medical News TodayAdrian Jacques Ambrose, MD, MPH, FAPA, medical director of the Columbia Psychiatry Faculty Practice Organization, discusses the newest research into the neuroscience of anxiety and depression.
Topic
-
Source:
Vice"There's no way that these drugs can meet the fantasized expectations that people have,” David Hellerstein, MD, a professor of clinical psychiatry at Columbia, said in reference to psychedelics.
Topic
-
Columbia Psychiatry is among the principal investigators in biotech Compass Pathways study of more than 200 patients.
Topic
-
Source:
New York Times"The unbridled enthusiasm and commercial momentum generated by psychedelics are excessive and ill advised until we have more sound research," writes Dr. Jeffrey Lieberman.
Topic
